Hip Implants Market Research Report - Global Forecast till 2025

Hip Implants Market Research Report - Global Forecast till 2025

ID: MRFR/HC/6976-HCR | November, 2019 | Region: Global | 111 pages | Half-Cooked Research Reports

Market Forecast


Hip Implants Market is expected to hold a value of USD 9,300 Million by 2025 at a CAGR of 4.1%.


Market Synopsis


Hip implants are medical devices used to relieve pain and restore mobility in patients suffering from hip-related problems. They usually associated with arthritis and other hip diseases or injuries. Increasing hip replacement surgeries is the primary factor attributed to the growth of the market.


Market Influencer


Technological advancements and product launches by key players in the market are likely to act as a promising factor for the growth of the market in the near future.


Market Drivers



  • Growing prevalence of hip-related disorders. For instance, as per a survey, nearly 130 million people are expected to incur osteoarthritis worldwide by 2050, of whom 40 million are likely to be severely disabled by it.

  • Increasing mergers & acquisitions by prominent players in the market. For instance, In September 2019, DePuy Synthes acquired assets of JointPoint, Inc. to enhance reproducibility in hip replacement and surgical accuracy.

  • Increasing demand for hip replacement surgeries

  • Introduction of custom-made implants

  • Growing geriatric population

  • Rise in incidence of accidental injuries


Market Restraints



  • Stringent government regulations on all-metal hip implants

  • Increasing recalls of hip implants


Segmentation


By Product




  • Total Hip Replacement Implants: Expected to hold the largest share, owing to the increasing geriatric population and increasing prevalence of hip-related disorders. For instance, according to a survey, in the period between 2015 to 2050, the world's population of people over 60 years will double from 12% to 22%. As the aging population rises, age-related degenerative diseases such as osteoarthritis and rheumatoid arthritis also increase. With the increase in these diseases, the demand for hip replacement surgeries also grows for which hip implants are used.




  • Fixed-Bearing Hip Implants: This segment accounts the least share of the market as the shell of the implant is fixed, which limits the motion.




  • Mobile-Bearing Total Hip Implants: Mobile-bearing total hip implants are developed as an alternative to fixed-bearing implants because of their advantages related to wear and range of motion.




  • Partial Hip Replacement Implants: This segment is expected to be the fastest-growing segment, owing to the rise in the incidence of accidental injuries. As per the survey, a total of 2,643,098 accidents occurred in Germany in 2017.




  • Hip Resurfacing Implants: In hip resurfacing, instead of removing the femoral head, it is trimmed and capped with a smooth metal covering.




  • Revision Hip Replacement Implants: Hip replacement implants can wear out for various reasons and may need to be replaced with the help of the revision of hip replacement surgery.




By Material




  • Metal-on-Polyethylene: This is expected to be the largest segment, owing to the increasing demand for polymer as it does not lead to side-effects associated with conventional devices.




  • Ceramic-on-Metal: This is expected to be the fastest-growing segment owing to slow deterioration and friction than all-metal hip implants.




  • Metal-on-Metal: These devices are expected to last longer than other hip implants. 




  • Ceramic-on-Polyethylene: This segment is likely to account for a significant share due to certain benefits such as wettability, firmness, and inertness of the alumina ceramic material.




  • Ceramic-on-Ceramic: Ceramic-on-ceramic implants have been widely used in total hip replacement surgeries as it has the well-wearing capacity and low inflammatory reaction.




By End-User




  • Hospitals: The largest segment, hospitals are usually the first place for the diagnosis and treatment of patients. A higher number of surgical procedures in the hospitals are projected to drive the growth of this segment during the forecast period.




  • Orthopedic Clinics: This is expected to be the fastest-growing segment owing to the presence of a well-developed infrastructure and availability of skilled surgeons.




  • Ambulatory Surgical Centers: Ambulatory care is provided in settings such as ambulatory surgical centers, dialysis clinics, hospital outpatient departments, and other health professionals.




  • Others: This segment includes research organizations and academic institutions.




By Region




  • Americas: The largest regional market. In countries such as the US and Canada, the growing prevalence of hip-related disorders and the presence of top players such as Zimmer Biomet Holdings, Inc., Exactech, Inc., OMNILife science, Inc., DJO Global, Inc., is contributing to the growth of the hip implants market in this region. For example, as per a survey in 2019, in the US, it has been estimated that 80% of the population over 65 years suffer from radiographic evidence of osteoarthritis (OA), and 60% of this subset has symptoms of osteoarthritis. Additionally, according to another survey in 2018, it was estimated that 30 million people in the US were affected by osteoarthritis.




  • Europe: The rapid innovation in technology, coupled with high research & development (R&D) expenditure in the field of hip replacement surgery, is expected to boost the growth of the hip implants market in the European region.




  • Asia-Pacific: Asia-Pacific is anticipated to be the fastest-growing region in the global hip implants market. The region is witnessing an increase in the geriatric population. For example, according to a survey, by 2050, one in four people in the region will be over 60 years. The people of older persons in the region is expected to triple between 2010 and 2050 and will reach approximately 1.3 billion people. The prevalence of osteoarthritis and joint-related disorders are high among the geriatric population. Hence, the demands for hip implant surgeries increased in this region.




  • Middle East & Africa: The smallest market due to limited healthcare infrastructure and limited exposure to technological advancements.




Key Players



  • Zimmer Biomet Holdings, Inc. (US)

  • Stryker Corporation (UK)

  • Smith & Nephew PLC (UK)

  • MicroPort Scientific Corporation (China)

  • Exactech, Inc. (US)

  • OMNILife science, Inc. (US)

  • Braun Melsungen AG (Germany)

  • DJO Global, Inc. (US)

  • Aesculap Implant Systems, LLC (US)

  • Corin (UK)

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL HIP IMPLANTS, BY PRODUCT

6.1. Overview

6.2. Total Hip Replacement Implants

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.2.1. Fixed-Bearing Hip Implants

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.2.2. Mobile-Bearing Total Hip Implants

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.3. Partial Hip Replacement Implants

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.4. Hip Resurfacing Implants

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

6.5. Revision Hip Replacement Implants

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025


7. GLOBAL HIP IMPLANTS, BY MATERIAL

7.1. Overview

7.2. Metal-on-Metal

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.3. Metal-on-Polyethylene

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.4. Ceramic-on-Metal

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.5. Ceramic-on-Polyethylene

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

7.6. Ceramic-on-Ceramic

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8. GLOBAL HIP IMPLANTS, BY END USER

8.1. Overview

8.2. Hospitals

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.3. Orthopedic Clinics

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.4. Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

8.5. Others

Market Estimates & Forecast, by Region, 2019–2025

Market Estimates & Forecast, by Country, 2019–2025

9. GLOBAL HIP IMPLANTS, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa


10. COMPANY LANDSCAPE

10.1.1. Overview

10.1.2. Competitive Analysis

11. COMPANY PROFILES

11.1. Zimmer Biomet Holdings, Inc.

11.1.1. Company Overview

11.1.2. Product Type Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Stryker Corporation

11.2.1. Company Overview

11.2.2. Product Type Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Smith & Nephew PLC

11.3.1. Company Overview

11.3.2. Product Type Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. MicroPort Scientific Corporation

11.4.1. Company Overview

11.4.2. Product Type Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Exactech, Inc.

11.5.1. Company Overview

11.5.2. Product Type Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. OMNIlife science, Inc.

11.6.1. Company Overview

11.6.2. Product Type Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. B. Braun Melsungen AG

11.7.1. Company Overview

11.7.2. Product Type Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. DJO Global, Inc.

11.8.1. Company Overview

11.8.2. Product Type Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Aesculap Implant Systems, LLC

11.9.1. Company Overview

11.9.2. Product Type Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Corin

11.10.1. Company Overview

11.10.2. Product Type Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Others

12. APPENDIX

12.1. References

12.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL HIP IMPLANTS SYNOPSIS, 2019–2025

TABLE 2 GLOBAL HIP IMPLANTS ESTIMATES & FORECAST, 2019–2025 (USD MILLION)

TABLE 3 GLOBAL HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 4 GLOBAL HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 5 GLOBAL HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 6 GLOBAL HIP IMPLANTS, BY REGION, 2019–2025 (USD MILLION)

TABLE 7 NORTH AMERICA: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 8 NORTH AMERICA: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 9 NORTH AMERICA: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 10 US: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 11 US: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 12 US: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 13 CANADA: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 14 CANADA: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 15 CANADA: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 16 LATIN AMERICA: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 17 LATIN AMERICA: HIP IMPLANTS, MATERIAL, 2019–2025 (USD MILLION)

TABLE 18 LATIN AMERICA: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 19 EUROPE: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 20 EUROPE: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 21 EUROPE: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 22 WESTERN EUROPE: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 23 WESTERN EUROPE: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 24 WESTERN EUROPE: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 25 EASTERN EUROPE: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 26 EASTERN EUROPE: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 27 EASTERN EUROPE: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 28 ASIA-PACIFIC: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 29 ASIA-PACIFIC: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 30 ASIA-PACIFIC: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: HIP IMPLANTS, BY PRODUCT, 2019–2025 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: HIP IMPLANTS, BY MATERIAL, 2019–2025 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: HIP IMPLANTS, BY END USER, 2019–2025 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HIP IMPLANTS

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HIP IMPLANTS

FIGURE 4 GLOBAL HIP IMPLANTS SHARE, BY PRODUCT, 2018 (%)

FIGURE 5 GLOBAL HIP IMPLANTS SHARE, BY MATERIAL, 2018 (%)

FIGURE 6 GLOBAL HIP IMPLANTS SHARE, BY END USER, 2018 (%)

FIGURE 7 GLOBAL HIP IMPLANTS SHARE, BY REGION, 2018 (%)

FIGURE 8 AMERICAS: HIP IMPLANTS SHARE BY REGION, 2018 (%)

FIGURE 9 NORTH AMERICA: HIP IMPLANTS SHARE, BY COUNTRY, 2018 (%)

FIGURE 10 EUROPE: HIP IMPLANTS SHARE, BY REGION, 2018 (%)

FIGURE 11 WESTERN EUROPE: HIP IMPLANTS SHARE, BY COUNTRY, 2018 (%)

FIGURE 12 ASIA-PACIFIC: HIP IMPLANTS SHARE, BY COUNTRY, 2018 (%)

FIGURE 13 MIDDLE EAST & AFRICA: HIP IMPLANTS SHARE, BY COUNTRY, 2018 (%)

FIGURE 14 GLOBAL HIP IMPLANTS: COMPANY SHARE ANALYSIS, 2018 (%)

FIGURE 15 ZIMMER BIOMET HOLDINGS, INC.: KEY FINANCIALS

FIGURE 16 ZIMMER BIOMET HOLDINGS, INC.: SEGMENTAL REVENUE

FIGURE 17 ZIMMER BIOMET HOLDINGS, INC.: REGIONAL REVENUE

FIGURE 18 STRYKER CORPORATION: KEY FINANCIALS

FIGURE 19 STRYKER CORPORATION: SEGMENTAL REVENUE

FIGURE 20 STRYKER CORPORATION: REGIONAL REVENUE

FIGURE 21 STRYKER CORPORATION: KEY FINANCIALS

FIGURE 22 STRYKER CORPORATION: SEGMENTAL REVENUE

FIGURE 23 STRYKER CORPORATION: REGIONAL REVENUE

FIGURE 24 SMITH & NEPHEW PLC: KEY FINANCIALS

FIGURE 25 SMITH & NEPHEW PLC: SEGMENTAL REVENUE

FIGURE 26 SMITH & NEPHEW PLC: REGIONAL REVENUE

FIGURE 27 MICROPORT SCIENTIFIC CORPORATION: KEY FINANCIALS

FIGURE 28 MICROPORT SCIENTIFIC CORPORATION: SEGMENTAL REVENUE

FIGURE 29 MICROPORT SCIENTIFIC CORPORATION: REGIONAL REVENUE

FIGURE 30 EXACTECH, INC.: KEY FINANCIALS

FIGURE 31 EXACTECH, INC.: SEGMENTAL REVENUE

FIGURE 32 EXACTECH, INC.: REGIONAL REVENUE

FIGURE 33 OMNILIFE SCIENCE, INC.: KEY FINANCIALS

FIGURE 34 OMNILIFE SCIENCE, INC.: SEGMENTAL REVENUE

FIGURE 35 OMNILIFE SCIENCE, INC.: REGIONAL REVENUE

FIGURE 36 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 37 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 38 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 39 DJO GLOBAL, INC.: KEY FINANCIALS

FIGURE 40 DJO GLOBAL, INC.: SEGMENTAL REVENUE

FIGURE 41 DJO GLOBAL, INC.: REGIONAL REVENUE

FIGURE 42 AESCULAP IMPLANT SYSTEMS, LLC: KEY FINANCIALS

FIGURE 43 AESCULAP IMPLANT SYSTEMS, LLC: SEGMENTAL REVENUE

FIGURE 44 AESCULAP IMPLANT SYSTEMS, LLC: REGIONAL REVENUE

FIGURE 45 CORIN: KEY FINANCIALS

FIGURE 46 CORIN: SEGMENTAL REVENUE

FIGURE 47 CORIN: REGIONAL REVENUE



This table of content is tentative and subject to change as the research progresses.

Please note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.